{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:41:51Z","timestamp":1777470111352,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["KCA126849A"],"award-info":[{"award-number":["KCA126849A"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG-028747"],"award-info":[{"award-number":["P30-AG-028747"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RO1-AG-19310"],"award-info":[{"award-number":["RO1-AG-19310"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK-072488"],"award-info":[{"award-number":["P30-DK-072488"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Baltimore Veterans Affairs Medical Research Service"},{"name":"Baltimore Geriatrics Research Education Clinical Center"},{"name":"Veterans Affairs Research Senior Career Scientist Award"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Biological Research For Nursing"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Interleukin 6 (IL-6) and its receptors are expressed in approximately half of breast cancer (BC) tissues, and high serum IL-6 levels are associated with poor prognosis. African American (AA) patients with BC have higher serum IL-6 levels compared to Caucasians, suggesting additional risk of disease-related complications in AAs. The purpose of this study was to compare IL-6 complex biomarkers in AA women with and without a history of BC. We conducted a secondary analysis of phenotypic data from two studies of weight loss in AA women with and without a history of BC who had similar age and adiposity. Biomarkers analyzed included tumor necrosis factor alpha (TNF-\u03b1), IL-6, IL-6 soluble receptor (IL6sr), and soluble glycoprotein 130 (GP130); IL6sr and GP130 were newly analyzed for this study. TNF-\u03b1 levels were 1.86 times higher in the BC group (N = 7) compared to those without BC (N = 10; p &lt; 0.001) despite similar age, weight, and body mass index. GP130 levels tended to be higher in women with BC; IL-6 and Il-6 sr were not different between groups. There was a strong correlation between GP130 and TNF-\u03b1 (r = .638; p = .006) in the group overall. High TNF-\u03b1 levels in the BC group and a strong correlation between GP130 and TNF-\u03b1 in the overall group suggest the presence of IL-6 complex initiated TNF-\u03b1 production. Further study is needed to evaluate IL-6 reduction through a variety of approaches, including weight loss and anti-IL-6 therapies, which may ultimately implicate the reduction of IL-6 complex associated BC-specific recurrence and mortality.<\/jats:p>","DOI":"10.1177\/1099800420945787","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T07:47:47Z","timestamp":1596527267000},"page":"218-222","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["IL-6 and Soluble Receptors in Overweight and Obese African American Women With and Without Breast Cancer"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2091-2018","authenticated-orcid":false,"given":"K. A.","family":"Griffith","sequence":"first","affiliation":[{"name":"The George Washington University Schools of Nursing and Medicine and George Washington University Cancer Center, Washington, DC, USA"},{"name":"Baltimore Veterans Administration Medical Center, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Baltimore Veterans Administration Medical Center, Baltimore, MD, USA"},{"name":"Division of Gerontology and Geriatric Medicine, Geriatric Research, Education, and Clinical Center, University of Maryland School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"issue":"1","key":"bibr1-1099800420945787","first-page":"383","volume":"61","author":"Badache A.","year":"2001","journal-title":"Cancer Research"},{"key":"bibr2-1099800420945787","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E., Mosca L., Collins P., Jane Geiger M., Grady D., Kornitzer M., McNabb M. A., Wenger N. K. (2006). Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. The New England Journal of Medicine, 355(2), 125\u2013137. PMID: 16837676. https:\/\/doi.org\/10.1056\/NEJMoa062462","DOI":"10.1056\/NEJMoa062462"},{"key":"bibr3-1099800420945787","doi-asserted-by":"crossref","unstructured":"Chung S., Zhu S., Friedmann E., Kelleher C., Kozlovsky A., Macfarlane K. W., Tkaczuk K. H. R., Ryan A. S., Griffith K. A. (2016). Weight loss with mindful eating in African American women following treatment for breast cancer: A longitudinal study. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 24(4), 1875\u20131881. https:\/\/doi.org\/10.1007\/s00520-015-2984-2","DOI":"10.1007\/s00520-015-2984-2"},{"key":"bibr4-1099800420945787","doi-asserted-by":"crossref","unstructured":"Deng J., Grande F., Neamati N. (2007). Small molecule inhibitors of stat3 signaling pathway. Current Cancer Drug Targets, 7(1), 91\u2013107. https:\/\/doi.org\/10.2174\/156800907780006922","DOI":"10.2174\/156800907780006922"},{"key":"bibr5-1099800420945787","doi-asserted-by":"crossref","unstructured":"Deshmukh S. K., Srivastava S. K., Bhardwaj A., Singh A. P., Tyagi N., Marimuthu S., Dyess D. L., Zotto V. D., Carter J. E., Singh S. (2015). Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget, 6(13), 11231\u201311241. https:\/\/doi.org\/10.18632\/oncotarget.3591","DOI":"10.18632\/oncotarget.3591"},{"key":"bibr6-1099800420945787","doi-asserted-by":"crossref","unstructured":"Garcia-Tu\u00f1\u00f3n I., Ricote M., Ruiz A., Fraile B., Paniagua R., Royuela M. (2005). IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Histopathology, 47(1), 82\u201389. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02178.x","DOI":"10.1111\/j.1365-2559.2005.02178.x"},{"key":"bibr7-1099800420945787","doi-asserted-by":"crossref","unstructured":"Gianni W., Ricci A., Gazzaniga P., Brama M., Pietropaolo M., Votano S., Patan\u00e8 F., Aglian\u00f2 A. M., Spera G., Marigliano V., Ammendola S., Agnusdei D., Migliaccio S., Scandurra R. (2004). Raloxifene modulates interleukin-6 and tumor necrosis factor-\u03b1 synthesis in vivo: Results from a pilot clinical study. Journal of Clinical Endocrinology and Metabolism, 89(12), 6097\u20136099. https:\/\/doi.org\/10.1210\/jc.2004-0795","DOI":"10.1210\/jc.2004-0795"},{"key":"bibr8-1099800420945787","doi-asserted-by":"crossref","unstructured":"Griffith K. A., Chung S., Zhu S., Ryan A. S. (2016). Insulin resistance and inflammation in black women with and without breast cancer: Cause for concern. Ethnicity and Disease, 11(4), 2003. https:\/\/doi.org\/10.18865\/ed.26.4.513.Keywords","DOI":"10.18865\/ed.26.4.513"},{"key":"bibr9-1099800420945787","doi-asserted-by":"crossref","unstructured":"Heo T.H., Wahler J., Suh N. (2016). Potential therapeutic implications of IL-6\/IL-6R\/gp130-targeting agents in breast cancer. Oncotarget, 7(13), 15460. https:\/\/doi.org\/10.18632\/oncotarget.7102","DOI":"10.18632\/oncotarget.7102"},{"key":"bibr10-1099800420945787","doi-asserted-by":"crossref","unstructured":"Hong S.S., Choi J. H., Lee S. Y., Park Y.H., Park K.Y., Lee J. Y., Kim J., Gajulapati V., Goo J.I., Singh S., Lee K., Kim Y. K., Im S. H., Ahn S.H., Rose-John S., Heo T.H., Rose-John S. (2015). A novel small-molecule inhibitor targeting the IL-6 receptor \u03b2 subunit, glycoprotein 130. Journal of Immunology, 195, 237\u2013245. https:\/\/doi.org\/10.4049\/jimmunol.1402908","DOI":"10.4049\/jimmunol.1402908"},{"issue":"9","key":"bibr11-1099800420945787","first-page":"2899","volume":"31","author":"Jiang X. P.","year":"2011","journal-title":"Anticancer Research"},{"key":"bibr12-1099800420945787","first-page":"6860","volume":"52","author":"Johnston P. G.","year":"1992","journal-title":"Cancer Research"},{"key":"bibr13-1099800420945787","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2001.01867.x"},{"key":"bibr14-1099800420945787","doi-asserted-by":"crossref","unstructured":"Leslie K., Gao S. P., Berishaj M., Podsypanina K., Ho H., Ivashkiv L., Bromberg J. (2010). Differential interleukin-6\/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Research, 12(5), R80. https:\/\/doi.org\/10.1186\/bcr2725","DOI":"10.1186\/bcr2725"},{"key":"bibr15-1099800420945787","doi-asserted-by":"crossref","unstructured":"Li H., Xiao H., Lin L., Jou D., Kumari V., Lin J., Li C. (2014). Drug design targeting protein\u2212protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: Discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6\/GP130 interface. Journal of Medicinal Chemistry, 57, 632\u2013641. https:\/\/doi.org\/10.1021\/jm401144z","DOI":"10.1021\/jm401144z"},{"key":"bibr16-1099800420945787","doi-asserted-by":"crossref","unstructured":"Liao D., Liu Z., Wrasidlo W. J., Luo Y., Nguyen G., Chen T., Xiang R., Reisfeld R. A. (2011). Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model. Cancer Research, 71(17), 5688\u20135696. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1264","DOI":"10.1158\/0008-5472.CAN-11-1264"},{"key":"bibr17-1099800420945787","doi-asserted-by":"crossref","unstructured":"Pakiz B., Flatt S. W., Bardwell W. A., Rock C. L., Mills P. J. (2011). Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors. International Journal of Behavioral Medicine, 18(4), 333\u2013341. https:\/\/doi.org\/10.1007\/s12529-010-9079-8","DOI":"10.1007\/s12529-010-9079-8"},{"key":"bibr18-1099800420945787","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez A., Ezquerro S., M\u00e9ndez-Gim\u00e9nez L., Becerril S., Fr\u00fchbeck G. (2015). Revisiting the adipocyte: A model for integration of cytokine signaling in the regulation of energy metabolism. American Journal of Physiology-Endocrinology and Metabolism, 309, 691\u2013714. https:\/\/doi.org\/10.1152\/ajpendo.00297.2015.Adipose","DOI":"10.1152\/ajpendo.00297.2015"},{"key":"bibr19-1099800420945787","doi-asserted-by":"crossref","unstructured":"Ryan A. S., Ortmeyer H. K., Sorkin J. D. (2012). Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance. American Journal of Physiology-Endocrinology and Metabolism, 302(1), E145\u2013152. https:\/\/doi.org\/10.1152\/ajpendo.00618.2010","DOI":"10.1152\/ajpendo.00618.2010"},{"key":"bibr20-1099800420945787","doi-asserted-by":"crossref","unstructured":"Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. (2011). The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta\u2014Molecular Cell Research, 1813(5), 878\u2013888. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","DOI":"10.1016\/j.bbamcr.2011.01.034"},{"key":"bibr21-1099800420945787","unstructured":"Zhang G. J., Adachi I. (1999). Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Research, 19(2B), 1427\u20131432. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10365118"}],"container-title":["Biological Research For Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1099800420945787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1099800420945787","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1099800420945787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:38:18Z","timestamp":1777383498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1099800420945787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1177\/1099800420945787"],"URL":"https:\/\/doi.org\/10.1177\/1099800420945787","relation":{},"ISSN":["1099-8004","1552-4175"],"issn-type":[{"value":"1099-8004","type":"print"},{"value":"1552-4175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]}}}